Novo Integrated Sciences Corp (NVOS) Long-Term Debt to Capital Coefficient

Symbol and logo of brand Novo Integrated Sciences (NVOS)

Novo Integrated Sciences (NVOS) management aims to merge scientific research with healthcare delivery to extend human life. The business relies on a network of decentralized centers and IT services, adhering to strict HIPAA standards and state licensing. This price trend chart on GURU.Markets shows a value of 0.00, while the company remains marginalized, utilizing questionable financing methods without a real market share.

NVOS Novo Integrated Sciences, Inc.: Long-Term Debt to Capital in the range 07/04/2022 - 11/16/2024

Analytical breakdowns for Novo Integrated Sciences

- share price and consensus valuation forecast:
Price Novo Integrated Sciences Inc|NVOS - Price Target Chart
- market capitalization details:
Market Value Novo Integrated Sciences, Inc.|NVOS - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Novo Integrated Sciences|NVOS - Book Capitalization|Market Capitalization to Book Value Ratio novointegrated.com|NVOS - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Novo Integrated Sciences|NVOS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio novointegrated.com|NVOS - Company Aggregate Debts|Debts to Book Value Novo Integrated Sciences, Inc.|NVOS - Company Long-Term Debt|Company Short-Term Indebtedness Novo Integrated Sciences|Intermediate Liquidity Ratio novointegrated.com
- business earnings and investment ratios data:
NVOS - Company Net Income
Summary company analysis:NVOS (Novo Integrated Sciences Inc)
Finished products of Novo Integrated Sciences, Inc.

The ratio is calculated as the proportion of liabilities with a maturity exceeding one year to equity. This metric determines the issuer's financial autonomy and the degree of dependence on long-term debt capital. For the non-cyclical healthcare business of Novo Integrated Sciences (NVOS), low leverage guarantees stability during macroeconomic shocks. Analyzing the long-term debt-to-equity ratio allows for an assessment of the balance between security and investment efficiency.

Analysis of competing companies

HCA (HCA Holdings) - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Tenet (THC)|FMS (Fresenius Medical) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Long-Term Liabilities to Capital|Universal Health Services Corp - Long-Term Debt to Capital|DVA - Long-Term Debt to Capital|RDNT (RadNet Corp) - Long-Term Debt to Equity Ratio|OPCH: Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Surgery Partners, Inc.|Long-Term Debt to Equity Ratio premierinc.com (PINC)|Long-Term Debt to Capital EYE|PGNY - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ardent Health Partners Inc ARDT|SEM: Long-Term Debt to Capital Ratio|ASTH: Long-Term Debt to Equity Ratio|Pediatrix Medical Group, Inc. - Long-Term Loans to Capital Ratio|usph.com (USPH) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio PNTG|Long-Term Debt to Equity Organogenesis Inc.|Long-Term Liabilities to Capital Nutex Health Hospitals NUTX|Long-Term Debt to Equity Ratio AUNA (Auna SA)|Long-Term Debt to Equity SBC (SBC Medical Group Holdings Inc.)|Long-Term Debt to Equity Evolus EOLS|CHS (CYH) - Long-Term Liabilities to Capital|SKIN: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient MDWD (MediWound Ltd.)|BTMD: Long-Term Debt to Capital|JYNT - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity DocGo|Long-Term Debt to Capital Ratio PIII (P3 Health)|Long-Term Debt to Equity Ratio GANX (Gain Therapeutics, Inc.)|Long-Term Loans to Capital Ratio EUDA|Long-Term Debt to Capital BMGL (Basel Medical Group Ltd)|CollPlant (CLGN) - Long-Term Liabilities to Capital|Cuprina Holdings - Long-Term Debt to Capital|Long-Term Indebtedness to Equity Concord Medical Services Holdings (CCM)|American Shared Hospital Services, Inc. (AMS) - Long-Term Debt to Equity|MEDIROM Corp - Long-Term Debt to Capital Coefficient|ALBT (Avalon GloboCare Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital dih.com|Long-Term Debt to Equity Ratio XAGE (Carmell Therapeutics)|Long-Term Loans to Capital Ratio NIVF|Long-Term Debt to Capital ATIP (ATI Physical Therapy, Inc.)|CareMax, Inc (CMAX) - Long-Term Liabilities to Capital|Kindly MD, Inc. - Long-Term Debt to Capital|MODV (modivcare.com) - Long-Term Debt to Capital Ratio|SSY (sunlinkhealth.com) - Long-Term Debt to Equity Ratio|IMAC Holdings Inc - Long-Term Debt to Capital Coefficient